人獸通用感染疾病治療的全球市場 (2023-2030年):類型·原因物質·藥物類別·給藥途徑·終端用戶·各流通管道的規模·佔有率·成長分析·預測

Global Zoonotic Disease Treatment Market Size, Share, Growth Analysis, By Types, By Causative Agent, By Drug Class, By Route of Administration, By End-Users, By Distribution Channel - Industry Forecast 2023-2030

出版日期: 2023年07月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球人獸通用感染疾病治療藥的市場規模在2021年估算為368億5,000萬美元，從2022年的389億7,000萬美元，在預測期間中將以5.8％的年複合成長率推移，成長到2030年610億美元的規模。

人畜共患疾病治療市場專注於治療可從動物傳播給人類的疾病。它包括一系列有效對抗人畜共患疾病的治療和預防措施。隨著人們對人畜共患疾病及其對公共健康的潛在影響的認識不斷增強，市場對創新治療解決方案的需求不斷增加。推動市場的關鍵因素包括醫學研究的進步、醫療保健投資的增加以及各國政府和組織在全球範圍內控制和預防人畜共患病的努力。

本報告提供全球人獸通用感染疾病治療藥的市場調查，彙整市場概要，市場的各種影響因素的分析，技術·革新趨勢，法律制度，市場規模的轉變·預測，各種區分·各地區的明細，競爭情形，主要企業簡介等資訊。

市場概要
市場規模
市場動態
促進因素
機會
阻礙因素
課題
主要市場洞察
技術分析
價格分析
供應鏈分析
價值鏈分析
市場生態系統
IP分析
貿易分析
Start-Ups分析
原料分析
革新矩陣
開發中產品的分析
宏觀經濟指標
主要投資分析
主要成功因素
競爭的程度
市場動態及預測
市場動態
促進因素
機會
阻礙因素
課題
法規情形
波特分析
Skyquest對未來阻礙的特別見解
全球人獸通用感染疾病治療藥市場:各類型
市場概要
狂犬病(恐水症)
結核
瘧疾
利什曼原蟲症
伊波拉病毒病
其他
全球人獸通用感染疾病治療藥市場:原因物質
市場概要
細菌
病毒
線蟲
嚙齒類
扁虱
其他
全球人獸通用感染疾病治療藥市場:各類藥物
市場概要
抗真菌性
抗菌
抗生素
其他
全球人獸通用感染疾病治療藥市場:各給藥途徑
市場概要
口服
局部·其他
全球人獸通用感染疾病治療藥市場:各終端用戶
市場概要
醫院
專門診所
居家照護等
全球人獸通用感染疾病治療藥市場:各流通管道
市場概要
醫院藥局
零售藥局
線上藥局等
全球人獸通用感染疾病治療藥市場:各地區
- 市場概要
- 北美
- 歐洲
- 亞太地區
- 南美
- 中東·非洲
競爭情形
- 前五名公司的比較
- 主要企業的市場上的地位
- 主要企業的招聘策略
- 主要成功策略
- 市場上最近的活動
- 主要企業的市場佔有率
- 主要的企業簡介
  - Zoetis Inc.
  - Merck & Co., Inc.
  - Sanofi S.A.
  - Boehringer Ingelheim International GmbH
  - Eli Lilly and Company
  - Bayer AG
  - Virbac
  - Vetoquinol S.A.
  - Ceva Sante Animale
  - Heska Corporation
  - Johnson & Johnson

簡介目錄

Product Code: SQMIG35I2117

Market Insights

Zoonotic Disease Treatment Market size was valued at USD 36.85 billion in 2021 and is poised to grow from USD 38.97 billion in 2022 to USD 61 billion by 2030, growing at a CAGR of 5.8% in the forecast period (2023-2030).

The Zoonotic Disease Treatment Market focuses on treating illnesses that can be transmitted from animals to humans. It encompasses a range of treatments and preventive measures to combat zoonotic diseases effectively. With growing awareness of zoonotic diseases and their potential impact on public health, the market is witnessing increasing demand for innovative treatment solutions. Key factors driving the market include advancements in medical research, increasing investments in healthcare, and rising efforts by governments and organizations to control and prevent zoonotic diseases globally.

Top-down and bottom-up approaches were used to estimate and validate the size of zoonotic disease treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Zoonotic Disease Treatment Market Segmental Analysis

Global Zoonotic Disease Treatment Market is segmented based on types, causative agent, drug class, and route of administration, end-users, distribution channel and region. Based on types the market is segmented into rabies, tuberculosis, malaria, leishmaniasis, Ebola virus disease, and others. Based on causative agent, the Zoonotic Disease Treatment Market is segmented into bacteria, virus, nematode, rodents, ticks, and others. Based on drug class, the market is segmented into anti-fungal, anti-bacterial, antibiotics, and others. Based on Route of Administration, the market is segmented into oral, topical and others. Based on end-users, the market is segmented into hospitals, specialty clinics, homecare and others. Based on distribution channel, the Zoonotic Disease Treatment Market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. Based on region, the global Zoonotic Disease Treatment Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The Zoonotic Disease Treatment Market is propelled by various factors. These include the growing prevalence of zoonotic diseases, an increased awareness of their transmission, the development of innovative and efficient treatments, and supportive government initiatives. Additionally, advancements in technology and higher investments in research and development contribute significantly to the market's growth. These combined efforts drive the market's expansion as healthcare professionals and authorities strive to combat and prevent the spread of zoonotic diseases effectively.

Restraints

Despite its substantial growth potential, the Zoonotic Disease Treatment Market faces certain restraints. These include the limited availability of effective treatment options and the high cost of treatment, which may impede market growth. Additionally, the introduction of generic medications and the expiration of patents on branded drugs could slow down market expansion. Inadequate healthcare infrastructure and a shortage of skilled healthcare workers in developing nations may also pose challenges for the market. Furthermore, the high capital expenditure required for research and development, coupled with a lack of awareness, could further restrict the market's rate of expansion.

Trends

The global prevalence of zoonotic diseases is on the rise, influenced by urbanization, deforestation, and climate change. This surge in zoonotic diseases has led to a growing need for efficient treatments and vaccines in the market. The adoption of the One Health approach, which recognizes the interconnection between human, animal, and environmental health, is gaining momentum in the zoonotic disease treatment market. As a result, companies are focusing on developing treatments that not only benefit human health but also enhance animal health and help in preventing the transmission of zoonotic diseases.

Executive Summary

Market Overview
Wheel of Fortune
Research Methodology
Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition
Market Dynamics & Outlook
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Regulatory Landscape
Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Zoonotic Disease Treatment Market by Types
Market Overview
Rabies
tuberculosis
malaria
leishmaniasis
Ebola virus disease
and others
Global Zoonotic Disease Treatment Market by Causative Agent
Market Overview
Bacteria
virus
nematode
rodents
ticks
and others
Global Zoonotic Disease Treatment Market by Drug Class
Market Overview
Anti-Fungal
Anti-Bacterial
Antibiotics
and Others
Global Zoonotic Disease Treatment Market by Route of Administration
Market Overview
Oral
Topical and Others.
Global Zoonotic Disease Treatment Market by End-Users
Market Overview
Hospitals
Specialty Clinics
Homecare and Others
Global Zoonotic Disease Treatment Market by Distribution Channel
Market Overview
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy and Others
Global Zoonotic Disease Treatment Market Size by Region
Market Overview
North America
USA
Canada
Europe
Germany
Spain
France
UK
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
By Development
By Company
By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021
Key Company Profiles
Zoetis Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merck & Co., Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sanofi S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boehringer Ingelheim International GmbH
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Eli Lilly and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bayer AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Virbac
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Vetoquinol S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Ceva Sante Animale
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Heska Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
In February 2021, Johnson & Johnson announced the success of its COVID-19 vaccine, which has also been authorized for emergency use in many countries. The company is also developing a vaccine for Zika virus and a vaccine for respiratory syncytial virus (RSV)
Company Overview
Business Segment Overview
Financial Updates
Key Developments